Mary Simcox

Title: Mary Simcox: Innovator in Cancer Treatment

Introduction

Mary Simcox is a prominent inventor based in Lexington, MA (US). She has made significant contributions to the field of cancer treatment through her innovative research and development of targeted therapies. Her work focuses on improving the delivery and effectiveness of active agents in treating cancer.

Latest Patents

Mary Simcox holds a patent for "HSP90-targeting conjugates and formulations thereof." This patent describes conjugates of an active agent attached to a targeting moiety, such as an HSP90 binding moiety, via a linker. The designed conjugates and particles aim to provide improved temporospatial delivery of the active agent, enhanced biodistribution and penetration in tumors, and decreased toxicity. Additionally, the patent outlines methods for making these conjugates, particles, and formulations, as well as methods for administering them to subjects in need, particularly for cancer treatment. She has 1 patent to her name.

Career Highlights

Mary Simcox is currently associated with Tarveda Therapeutics, Inc., where she continues her groundbreaking work in the field of oncology. Her research has the potential to transform cancer treatment and improve patient outcomes.

Collaborations

Mary has collaborated with notable colleagues, including Benoît Moreau and Brian H White, to advance her research and develop innovative solutions in cancer therapy.

Conclusion

Mary Simcox is a dedicated inventor whose work in HSP90-targeting conjugates represents a significant advancement in cancer treatment. Her contributions are paving the way for more effective therapies that can improve the lives of patients battling cancer.